WeTrials
Recruiting

A Phase Ib/II, Open-label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic Breast Cancer (Morpheus-panBC)

What is this study?

This study is testing different combinations of modern cancer treatments, such as immunotherapy and targeted therapies, for adults with advanced breast cancer. The goal is to find safer and more effective treatment options tailored to specific types of breast cancer.

Who can participate?

Adults aged 18 and older with advanced or metastatic breast cancer that cannot be removed by surgery may be eligible. Specific requirements depend on your breast cancer type and previous treatments you have received.

What will happen?

You will be assigned to a specific treatment combination designed for your type of breast cancer and closely monitored by the medical team. Depending on how your body responds and which group you are in, you might have the option to try a different medication combination later on.

Where and when?

The study is currently recruiting participants at multiple locations, including sites in California, United States. Your care team can help you find the most convenient location.

Key Points
  • 1Evaluates multiple new treatment combinations for advanced breast cancer
  • 2Tailored to specific types of breast cancer and genetic mutations
  • 3Currently recruiting participants and actively enrolling

Related links

Outside pages about this study, checked by our team

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Metastatic Breast Cancer

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.